Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.06 Billion USD | 4.25% |
| 2022 | 1.97 Billion USD | 6.42% |
| 2021 | 1.85 Billion USD | 18.49% |
| 2020 | 1.56 Billion USD | 24.11% |
| 2019 | 1.26 Billion USD | 76.09% |
| 2018 | 717.11 Million USD | -11.85% |
| 2017 | 813.48 Million USD | 10.82% |
| 2016 | 734.02 Million USD | 7.14% |
| 2015 | 685.08 Million USD | 2.29% |
| 2014 | 669.74 Million USD | -7.8% |
| 2013 | 726.4 Million USD | -0.57% |
| 2012 | 730.59 Million USD | -14.88% |
| 2011 | 858.28 Million USD | -33.97% |
| 2010 | 1.29 Billion USD | 10.87% |
| 2009 | 1.17 Billion USD | 9.55% |
| 2008 | 1.07 Billion USD | 82.28% |
| 2007 | 587.11 Million USD | 26.6% |
| 2006 | 463.75 Million USD | 36.4% |
| 2005 | 339.99 Million USD | 70.23% |
| 2004 | 199.73 Million USD | 115.99% |
| 2003 | 92.47 Million USD | 58.55% |
| 2002 | 58.32 Million USD | 22.43% |
| 2001 | 47.64 Million USD | 14.6% |
| 2000 | 41.57 Million USD | -1.22% |
| 1999 | 42.08 Million USD | -5.28% |
| 1998 | 44.42 Million USD | 94.26% |
| 1997 | 22.87 Million USD | 35.66% |
| 1996 | 16.85 Million USD | 46.6% |
| 1995 | 11.5 Million USD | 82.54% |
| 1994 | 6.3 Million USD | 46.51% |
| 1993 | 4.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.11 Billion USD | 1.32% |
| 2024 Q1 | 2.08 Billion USD | 1.44% |
| 2023 Q1 | 1.94 Billion USD | -1.48% |
| 2023 Q3 | 2.02 Billion USD | 2.27% |
| 2023 Q2 | 1.98 Billion USD | 1.82% |
| 2023 Q4 | 2.06 Billion USD | 1.62% |
| 2023 FY | 2.06 Billion USD | 4.25% |
| 2022 Q3 | 1.98 Billion USD | -0.94% |
| 2022 FY | 1.97 Billion USD | 6.42% |
| 2022 Q1 | 1.9 Billion USD | 2.77% |
| 2022 Q2 | 2 Billion USD | 4.85% |
| 2022 Q4 | 1.97 Billion USD | -0.3% |
| 2021 Q2 | 1.59 Billion USD | 1.68% |
| 2021 Q3 | 1.93 Billion USD | 21.14% |
| 2021 FY | 1.85 Billion USD | 18.49% |
| 2021 Q1 | 1.57 Billion USD | 0.38% |
| 2021 Q4 | 1.85 Billion USD | -4.16% |
| 2020 Q2 | 1.64 Billion USD | 14.26% |
| 2020 Q4 | 1.56 Billion USD | -2.22% |
| 2020 Q3 | 1.6 Billion USD | -2.6% |
| 2020 Q1 | 1.44 Billion USD | 14.04% |
| 2020 FY | 1.56 Billion USD | 24.11% |
| 2019 Q1 | 1.18 Billion USD | 65.14% |
| 2019 FY | 1.26 Billion USD | 76.09% |
| 2019 Q4 | 1.26 Billion USD | 4.15% |
| 2019 Q2 | 1.2 Billion USD | 1.83% |
| 2019 Q3 | 1.21 Billion USD | 0.54% |
| 2018 Q2 | 753.32 Million USD | -10.56% |
| 2018 Q3 | 725.89 Million USD | -3.64% |
| 2018 Q4 | 717.11 Million USD | -1.21% |
| 2018 Q1 | 842.28 Million USD | 3.54% |
| 2018 FY | 717.11 Million USD | -11.85% |
| 2017 Q2 | 805.87 Million USD | 6.51% |
| 2017 Q3 | 799.52 Million USD | -0.79% |
| 2017 Q4 | 813.48 Million USD | 1.75% |
| 2017 Q1 | 756.62 Million USD | 3.08% |
| 2017 FY | 813.48 Million USD | 10.82% |
| 2016 FY | 734.02 Million USD | 7.14% |
| 2016 Q3 | 721.73 Million USD | 1.49% |
| 2016 Q4 | 734.02 Million USD | 1.7% |
| 2016 Q1 | 705.64 Million USD | 3.0% |
| 2016 Q2 | 711.1 Million USD | 0.77% |
| 2015 Q2 | 645.43 Million USD | 3.55% |
| 2015 Q1 | 623.32 Million USD | -6.93% |
| 2015 FY | 685.08 Million USD | 2.29% |
| 2015 Q4 | 685.08 Million USD | 2.8% |
| 2015 Q3 | 666.43 Million USD | 3.25% |
| 2014 Q2 | 710.29 Million USD | -2.35% |
| 2014 Q4 | 669.74 Million USD | -1.83% |
| 2014 FY | 669.74 Million USD | -7.8% |
| 2014 Q1 | 727.39 Million USD | 0.14% |
| 2014 Q3 | 682.21 Million USD | -3.95% |
| 2013 Q3 | 754.56 Million USD | 7.76% |
| 2013 FY | 726.4 Million USD | -0.57% |
| 2013 Q2 | 700.25 Million USD | -1.69% |
| 2013 Q4 | 726.4 Million USD | -3.73% |
| 2013 Q1 | 712.31 Million USD | -2.5% |
| 2012 Q4 | 730.59 Million USD | -16.57% |
| 2012 Q1 | 855.38 Million USD | -0.34% |
| 2012 Q2 | 858.29 Million USD | 0.34% |
| 2012 Q3 | 875.72 Million USD | 2.03% |
| 2012 FY | 730.59 Million USD | -14.88% |
| 2011 Q1 | 1.32 Billion USD | 2.13% |
| 2011 FY | 858.28 Million USD | -33.97% |
| 2011 Q2 | 1.34 Billion USD | 0.99% |
| 2011 Q3 | 846.77 Million USD | -36.84% |
| 2011 Q4 | 858.28 Million USD | 1.36% |
| 2010 FY | 1.29 Billion USD | 10.87% |
| 2010 Q1 | 1.22 Billion USD | 4.27% |
| 2010 Q2 | 1.26 Billion USD | 3.83% |
| 2010 Q4 | 1.29 Billion USD | 2.84% |
| 2010 Q3 | 1.26 Billion USD | -0.42% |
| 2009 Q2 | 1.08 Billion USD | -0.28% |
| 2009 Q4 | 1.17 Billion USD | 3.66% |
| 2009 Q3 | 1.13 Billion USD | 4.39% |
| 2009 Q1 | 1.08 Billion USD | 1.51% |
| 2009 FY | 1.17 Billion USD | 9.55% |
| 2008 FY | 1.07 Billion USD | 82.28% |
| 2008 Q1 | 1.03 Billion USD | 76.75% |
| 2008 Q2 | 1.02 Billion USD | -1.47% |
| 2008 Q3 | 1.05 Billion USD | 2.77% |
| 2008 Q4 | 1.07 Billion USD | 1.85% |
| 2007 Q2 | 518.67 Million USD | 7.36% |
| 2007 FY | 587.11 Million USD | 26.6% |
| 2007 Q3 | 564.72 Million USD | 8.88% |
| 2007 Q1 | 483.11 Million USD | 4.17% |
| 2007 Q4 | 587.11 Million USD | 3.96% |
| 2006 Q1 | 339.51 Million USD | -0.14% |
| 2006 FY | 463.75 Million USD | 36.4% |
| 2006 Q2 | 347.68 Million USD | 2.41% |
| 2006 Q3 | 370.18 Million USD | 6.47% |
| 2006 Q4 | 463.75 Million USD | 25.28% |
| 2005 Q3 | 330.6 Million USD | 41.94% |
| 2005 FY | 339.99 Million USD | 70.23% |
| 2005 Q4 | 339.99 Million USD | 2.84% |
| 2005 Q2 | 232.91 Million USD | 6.98% |
| 2005 Q1 | 217.72 Million USD | 9.01% |
| 2004 Q1 | 106.12 Million USD | 14.77% |
| 2004 FY | 199.73 Million USD | 115.99% |
| 2004 Q4 | 199.73 Million USD | 6.29% |
| 2004 Q3 | 187.91 Million USD | 69.27% |
| 2004 Q2 | 111.01 Million USD | 4.6% |
| 2003 Q2 | 60.06 Million USD | 3.56% |
| 2003 Q1 | 58 Million USD | -0.55% |
| 2003 Q4 | 92.47 Million USD | 36.62% |
| 2003 FY | 92.47 Million USD | 58.55% |
| 2003 Q3 | 67.68 Million USD | 12.68% |
| 2002 Q4 | 58.32 Million USD | -11.23% |
| 2002 Q2 | 63.63 Million USD | 50.91% |
| 2002 Q1 | 42.16 Million USD | -11.49% |
| 2002 FY | 58.32 Million USD | 22.43% |
| 2002 Q3 | 65.7 Million USD | 3.26% |
| 2001 Q3 | 43.31 Million USD | 12.93% |
| 2001 FY | 47.64 Million USD | 14.6% |
| 2001 Q2 | 38.35 Million USD | -20.2% |
| 2001 Q1 | 48.06 Million USD | 15.62% |
| 2001 Q4 | 47.64 Million USD | 10.0% |
| 2000 FY | 41.57 Million USD | -1.22% |
| 2000 Q2 | 42.3 Million USD | 5.44% |
| 2000 Q4 | 41.57 Million USD | 2.98% |
| 2000 Q3 | 40.36 Million USD | -4.59% |
| 2000 Q1 | 40.12 Million USD | -10.04% |
| 1999 Q1 | 50.6 Million USD | 13.89% |
| 1999 Q4 | 44.6 Million USD | -10.26% |
| 1999 Q3 | 49.7 Million USD | -11.88% |
| 1999 FY | 42.08 Million USD | -5.28% |
| 1999 Q2 | 56.4 Million USD | 11.46% |
| 1998 FY | 44.42 Million USD | 94.26% |
| 1998 Q3 | 23.4 Million USD | -24.27% |
| 1998 Q4 | 44.42 Million USD | 89.86% |
| 1998 Q1 | 25.9 Million USD | 13.25% |
| 1998 Q2 | 30.9 Million USD | 19.31% |
| 1997 Q3 | 21 Million USD | 7.69% |
| 1997 Q2 | 19.5 Million USD | 7.73% |
| 1997 FY | 22.87 Million USD | 35.66% |
| 1997 Q1 | 18.1 Million USD | 7.36% |
| 1997 Q4 | 22.87 Million USD | 8.9% |
| 1996 Q2 | 14.6 Million USD | 13.18% |
| 1996 Q3 | 15.9 Million USD | 8.9% |
| 1996 FY | 16.85 Million USD | 46.6% |
| 1996 Q1 | 12.9 Million USD | 12.17% |
| 1996 Q4 | 16.85 Million USD | 6.03% |
| 1995 FY | 11.5 Million USD | 82.54% |
| 1995 Q2 | 10.2 Million USD | 52.24% |
| 1995 Q1 | 6.7 Million USD | 6.35% |
| 1995 Q3 | 10 Million USD | -1.96% |
| 1995 Q4 | 11.5 Million USD | 15.0% |
| 1994 FY | 6.3 Million USD | 46.51% |
| 1994 Q4 | 6.3 Million USD | 0.0% |
| 1994 Q2 | 5.5 Million USD | 7.84% |
| 1994 Q1 | 5.1 Million USD | 18.6% |
| 1993 FY | 4.3 Million USD | 0.0% |
| 1993 Q4 | 4.3 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 61.556% |
| Addus HomeCare Corporation | 1.02 Billion USD | -101.105% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -864.716% |
| American Oncology Network, Inc. | 374.45 Million USD | -450.181% |
| Astrana Health, Inc. | 933.36 Million USD | -120.726% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | -25.838% |
| IMAC Holdings, Inc. | 1.14 Million USD | -179966.06% |
| biote Corp. | 155.29 Million USD | -1226.617% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -3265.149% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | -203.271% |
| COMPASS Pathways plc | 275.98 Million USD | -646.474% |
| DocGo Inc. | 490.45 Million USD | -320.055% |
| The Ensign Group, Inc. | 4.17 Billion USD | 50.685% |
| Healthcare Services Group, Inc. | 803.18 Million USD | -156.501% |
| InnovAge Holding Corp. | 547.66 Million USD | -276.176% |
| Assure Holdings Corp. | 7.51 Million USD | -27317.754% |
| The Joint Corp. | 87.15 Million USD | -2263.912% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 7.748% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -25812.084% |
| ModivCare Inc. | 1.76 Billion USD | -16.573% |
| NewGenIvf Group Limited | 1.64 Million USD | -124951.291% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -5693.008% |
| Option Care Health, Inc. | 3.32 Billion USD | 38.102% |
| P3 Health Partners Inc. | 860.96 Million USD | -139.286% |
| P3 Health Partners Inc. | 860.96 Million USD | -139.286% |
| The Pennant Group, Inc. | 539.69 Million USD | -281.731% |
| Surgery Partners, Inc. | 7.01 Billion USD | 70.649% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -41745.452% |
| Talkspace, Inc. | 142.22 Million USD | -1348.569% |
| Talkspace, Inc. | 142.22 Million USD | -1348.569% |
| The Oncology Institute, Inc. | 219.41 Million USD | -838.925% |
| The Oncology Institute, Inc. | 219.41 Million USD | -838.925% |